FirmaIQ
Org.nr 991 036 393 2016 → 2017 Year-over-year analysis

PCI BIOTECH HOLDING ASA: årsregnskap 2017 vs 2016

Weaker earnings, cash halved-plus

approved 2018-05-29; registry 2018-06-15; journal 2018 471525

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2017 with 2016 for PCI BIOTECH HOLDING ASA. Revenue 0 NOK → 0 NOK (0.0%). Net result +146.52m NOK → +34.15m NOK. Equity 223.57m NOK → 329.3k NOK.

Pressures included: net result weakened; equity eroded; cash fell.

Also worth watching: sharp cash drawdown; paid-in equity reduced; book investments changed. All figures are taken from the published annual accounts for PCI BIOTECH HOLDING ASA.

At a glance

Scorecard

Revenue
0 NOK 0 NOK
0.0%
Net result
+146.52m NOK +34.15m NOK
-76.7%
Equity
223.57m NOK 329.3k NOK
-99.9%
Cash
14.00m NOK 759 NOK
-100.0%
Total assets
224.63m NOK 330.4k NOK
-99.9%

What deteriorated

  • ↓

    Net result weakened

    Net result +146.52m NOK → +34.15m NOK. Calculated

  • ↓

    Equity eroded

    Book equity 223.57m NOK → 329.3k NOK (equity ratio 99.5% → 99.7%). Calculated

  • ↓

    Cash fell

    Bank deposits 14.00m NOK → 759 NOK (-100.0% YoY). Calculated

Things to notice

  • ·

    Sharp cash drawdown

    Cash fell by more than 60% YoY (14.00m NOK → 759 NOK). Check whether funds moved to group receivables, investments, or operating burn. Interpretation

  • ·

    Paid-in equity reduced

    Paid-in equity fell 165.38m NOK → 232.1k NOK — check capital reduction, conversion, or reclassification. Interpretation

  • ·

    Book investments changed

    Investment / intangible book value 223.50m NOK → 302.2k NOK. Reported fact